Researchers aim to ensure future AI healthcare monitoring systems are free of gender bias
The project will train a newly developed AI system on data collected from participating men and women
Read More
Tag: James Watt School of Engineering
- Acesion Pharma launches phase 2 trial of AP31969 in atrial fibrillation
- Johnson & Johnson seeks EMA approval for teclistamab–daratumumab combination
- HUTCHMED begins phase 3 stage of pancreatic cancer trial
- Zenas reports strong phase 3 results for obexelimab in IgG4-related disease
- MRM Health collaborates with Oncode Institute and Netherlands Cancer Institute
